Kline, RA; Wishart, TM; Mills, K; Heywood, WE; (2020) Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease , 1866 (9) , Article 165498. 10.1016/j.bbadis.2019.06.012.

Preview	Text (Article) Heywood_1-s2.0-S092544391930211X-main.pdf - Accepted Version Download (1MB) | Preview
Preview	Text (Supplementary Information) Heywood_Supplementary information for BBA review.pdf - Accepted Version Download (501kB) | Preview

Abstract

The Neuronal Ceroid Lipofuscinoses are a group of severe and progressive neurodegenerative disorders, which generally present during childhood. With new treatments emerging on the horizon, there is a growing need to understand the specific disease mechanisms as well as identify prospective biomarkers for use to stratify patients and monitor treatment. The use of Omics technologies to NCLs has the potential to address this need. We discuss the recent use and outcomes of Omics to various forms of NCL including identification of interactomes, affected biological pathways and potential biomarker candidates. We also identify common pathways affected in NCL across the reviewed studies.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as CSVXMLJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item